HIV treatment strategies - Planning for the long term

[1] CAMERON DW, 1998, 5 C RETR OPP INF FEB

[2] Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24): : 1962 - 1969

[3] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) : 13193 - 13197

[4] CLENDENNIN N, 1998, 5 C RETR OPP INF FEB

[5] Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor [J]. JOURNAL OF VIROLOGY, 1996, 70 (12) : 8270 - 8276

[6] IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J]. NATURE, 1995, 374 (6522) : 569 - 571

[7] CONNICK E, 1998, 5 C RETR OPP INF FEB

[8] Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection - A randomized, double-blind, placebo-controlled trial [J]. ANNALS OF INTERNAL MEDICINE, 1996, 124 (12) : 1019 - 1030

[9] Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy [J]. SCIENCE, 1997, 278 (5341) : 1295 - 1300

[10] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) : 734 - 739

[1] CAMERON DW, 1998, 5 C RETR OPP INF FEB

[2] Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24): : 1962 - 1969

[3] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) : 13193 - 13197

[4] CLENDENNIN N, 1998, 5 C RETR OPP INF FEB

[5] Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor [J]. JOURNAL OF VIROLOGY, 1996, 70 (12) : 8270 - 8276

[6] IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J]. NATURE, 1995, 374 (6522) : 569 - 571

[7] CONNICK E, 1998, 5 C RETR OPP INF FEB

[8] Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection - A randomized, double-blind, placebo-controlled trial [J]. ANNALS OF INTERNAL MEDICINE, 1996, 124 (12) : 1019 - 1030

[9] Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy [J]. SCIENCE, 1997, 278 (5341) : 1295 - 1300

[10] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) : 734 - 739